Blog

See the FDA’s Updated Guidance on Compounding Animal Drugs

The U.S. Food and Drug Administration (FDA) issued an update guidance, titled Compounding Animal Drugs from Bulk Drug Substances. This guidance is a continuation of...

Read The Article

What CITI Program is Reading – September 7th, 2022

“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,...

Read The Article

HHS Requests Input on Public Health Service Policies on Research Misconduct

The U.S. Department of Health and Human Services (HHS), Office of Research Integrity is seeking input from individuals, research funding agencies, institutional officials, organizations, institutions,...

Read The Article

FDA Authorizes Bivalent COVID-19 Vaccines for Use as a Booster Dose

The U.S. Food and Drug Administration (FDA) has approved bivalent formulations of the Moderna and Pfizer-BioNTech COVID-19 vaccines as a single booster dose. See the...

Read The Article

What CITI Program is Reading – August 30th, 2022

“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,...

Read The Article

CITI Program’s August 2022 Media Playlist – Part 3

CITI Program’s media playlists highlight content curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for...

Read The Article

Revised FDA Draft Guidance on Charging for Investigational Drugs

The U.S. Food and Drug Administration (FDA) issued a revised draft guidance, entitled Charging for Investigational Drugs Under an IND Questions and Answers. When finalized,...

Read The Article

What CITI Program is Reading – August 23rd, 2022

“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,...

Read The Article

Biosafety – Assessing and Managing Risks

Introduction Clinical and research environments may be host to a variety of biohazards. These environments include clinical and microbiological laboratories; biomedical research and biotechnology facilities;...

Read The Article

What CITI Program is Reading – August 16th, 2022

“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,...

Read The Article